Table 3.

Shows ACh-induced SKCa-dependent BP reduction deviations comparisions after fluoroquinolones treatment.

Comparisons
Group	$(\frac{\mathbf{s}\mathbf{y}\mathbf{s}\mathbf{t}\mathbf{o}\mathbf{l}\mathbf{i}\mathbf{c}(\mathbf{a}\mathbf{p}+\mathbf{A}\mathbf{C}\mathbf{h})-\mathbf{s}\mathbf{y}\mathbf{s}\mathbf{t}\mathbf{o}\mathbf{l}\mathbf{i}\mathbf{c}(\mathbf{A}\mathbf{C}\mathbf{h})}{\mathit{systolic}})\mathit{average}$	$(\frac{\mathbf{d}\mathbf{i}\mathbf{a}\mathbf{s}\mathbf{t}\mathbf{o}\mathbf{l}\mathbf{i}\mathbf{c}(\mathbf{a}\mathbf{p}+\mathbf{A}\mathbf{C}\mathbf{h})-\mathbf{d}\mathbf{i}\mathbf{a}\mathbf{s}\mathbf{t}\mathbf{o}\mathbf{l}\mathbf{i}\mathbf{c}(\mathbf{A}\mathbf{C}\mathbf{h})}{\mathit{diastolic}})\mathit{average}$	$(\frac{\mathbf{m}\mathbf{e}\mathbf{a}\mathbf{n}(\mathbf{a}\mathbf{p}+\mathbf{A}\mathbf{C}\mathbf{h})-\mathbf{m}\mathbf{e}\mathbf{a}\mathbf{n}(\mathbf{A}\mathbf{C}\mathbf{h})}{\mathit{mean}})\mathit{average}$
Moxi ratio (n = 12)	0.153 ± 0.149	0.131 ± 0.102	0.141∗ ±0.075
Levo ratio (n = 15)	0.065 ± 0.100	0.069 ± 0.103	0.060∗ ±0.061
Diabetics ratio (n = 15)	0.045 ± 0.130	0.037 ± 0.094	0.041 ± 0.068
Normals ratio (n = 6)	0.155 ± 0.221	0.163 ± 0.125	0.156∗ ±0.109

Using One-Way ANOVA test indicated statistically significant differences in mean BP deviations among studied groups (F = 6.559,p < 0.05), Tukey test indicated a statistically significant difference in mean BP deviations between moxifloxacin and levofloxacin group (p < 0.05), as well as between levofloxacin and non-diabetic group (p < 0.05), on the other hand, One-Way ANOVA test indicated statistically non-significant differences in diastolic and systolic BP deviations among the four studied groups.